Shockwave Therapy for Carpal Tunnel Syndrome: What the Evidence Shows

Carpal tunnel syndrome is compression of the median nerve at the wrist, and the standard non-surgical options are a night splint, activity and load modification, and a corticosteroid injection. Surgery follows when those fail or when the compression is severe.

Shockwave therapy arrived in this space carrying its reputation from tendinopathy, where the evidence for stubborn heel and Achilles pain is reasonably good. Carpal tunnel is a nerve compression problem rather than a tendon problem, so the reputation does not transfer automatically. The question is whether the trials in carpal tunnel specifically support it, and there the picture is more complicated.

Two systematic reviews frame the debate, and they reach different conclusions from overlapping data.

A 2022 systematic review and meta-analysis of seven randomised trials covering 376 participants found significant improvement in function and symptoms only at four weeks, with no advantage over a night splint alone at 8 to 10 weeks or at 12 to 14 weeks. Its conclusion was that the therapeutic effect is transient and largely does not persist.

An updated 2023 review of ten trials and 476 patients was more favourable, reporting greater improvement in function scores, pain scores and nerve conduction measures than control across the follow-up period, including better results than corticosteroid injection at three and six months. The authors themselves graded the certainty of that evidence as low, because of risk of bias, inconsistency between trials and imprecision.

Both reviews agree on safety: no serious adverse effects were reported. So the honest summary is that shockwave is a low-risk treatment with promising but low-certainty evidence in mild to moderate carpal tunnel syndrome, and that some of the effect measured at four weeks may not last.

• Night splinting holds the wrist in neutral overnight, which is when pressure in the tunnel peaks for most people. It is cheap, safe and the first thing worth trying. Several of the shockwave trials used splinting as their comparator, which is why the four-week difference matters less than it first appears.
• Corticosteroid injection produces reliable short-to-medium term relief for many people, and a good response to it is also a useful diagnostic signal that the median nerve at the wrist is genuinely the source.
• Load and activity modification is unglamorous and frequently the thing that changes the trajectory, particularly where vibrating tools, sustained gripping or a poorly set-up workstation are involved.
• Surgical release is the definitive option for moderate to severe compression, and delaying it for years in a severely compressed nerve risks leaving permanent numbness. Our article on carpal tunnel release recovery covers what that involves.

On the current evidence, shockwave is worth a conversation if your symptoms are mild to moderate, splinting and load changes have helped only partly, you would rather avoid or delay an injection, and you understand that the benefit may be short-lived.

It is a poor choice where the compression is severe, where there is constant numbness, visible wasting of the muscle at the base of the thumb, or nerve conduction studies showing marked slowing. Those findings point towards surgical release, and time spent on trials of anything else is time the nerve does not get back.

It is also the wrong treatment if the symptoms are not actually coming from the carpal tunnel. Nerve irritation in the neck, thoracic outlet problems and generalised nerve conditions all produce hand tingling, and assessment separates them before any treatment is chosen.

Typically three to five sessions at weekly intervals, each a few minutes of treatment over the front of the wrist, alongside continued splinting and a home programme of nerve and tendon gliding. Treatment is uncomfortable rather than painful, and a day or two of local soreness afterwards is normal.

Two things are worth agreeing before you start. Set a review point, usually after three sessions, at which you decide together whether anything is genuinely changing. And agree what happens if it does not, because the value of a short trial is that it ends cleanly and sends you on to the option that will work.

The belief people arrive holding is that shockwave is a stronger version of physiotherapy, so if the standard treatment did not fix the hand, the machine will. That is not how the evidence reads. Shockwave has good support in a narrow set of stubborn tendon problems and low-certainty support in mild to moderate carpal tunnel, and the difference between those two statements decides whether it is worth your money.

In East Sussex, the route from a compressed nerve to an operation runs through the MSK partnership that East Sussex Healthcare NHS Trust and Horder Healthcare run jointly, which is where nerve conduction testing and a surgical opinion sit. What matters clinically is where you are on that road. A hand with intermittent night tingling and a normal thumb muscle bulk has room to trial conservative options, including shockwave. A hand with constant numbness and thenar wasting does not, and offering it a course of anything other than a surgical opinion wastes months that the nerve is spending under pressure.

If a tendon or nerve problem has already failed the standard options, shockwave therapy in Uckfield starts with an assessment to work out whether it is the right tool at all.

Does shockwave therapy cure carpal tunnel syndrome?
No treatment short of surgical release reliably removes the compression. Shockwave has shown symptom and function improvements in trials, with low certainty and questions about how long the effect lasts.

Is it painful?
Uncomfortable during application and often a little sore for a day afterwards. Serious adverse effects were not reported in the published trials.

How many sessions before I know?
Three sessions is a fair trial. If nothing has shifted by then, the sensible move is to change approach rather than to keep going.

Can I have it if I am waiting for surgery?
Usually yes for mild to moderate symptoms, but tell the surgical team. If your compression is severe, the priority is the operation rather than filling the wait with treatment.

Will it work if my symptoms come from my neck?
No. Treating the wrist for a problem originating at the neck is a common reason treatment fails, which is why the assessment comes first.